期刊文献+

羟考酮控释片作为止痛背景用药在中重度癌痛滴定中的临床观察 被引量:23

Effect of oxycodone controlled-release tablets in titration of moderate or severe cancer pain for background
下载PDF
导出
摘要 目的评价羟考酮控释片在中重度癌痛滴定中的有效性和安全性。方法 81例既往未接受阿片类药物治疗的中重度癌痛(疼痛评分>3)患者随机分成2组:A组(42例)接受吗啡即释片10 mg q4 h滴定;B组(39例)接受羟考酮控释片10 mg q12 h为背景止痛药的滴定。后按照NCCN疼痛治疗指南的要求滴定,24 h后2组均根据吗啡使用总量调整羟考酮控释片用量。观察期为24 h,服药后1 h开始根据疼痛数字评价量表(NRS)进行评分,比较两组疗效和不良反应的发生率。结果 24 h观察期内吗啡即释片组的疼痛缓解率为82.9%,羟考酮控释片组为87.2%;滴定4 h,吗啡即释片组的疼痛缓解率为58.3%,羟考酮控释片组为77.0%,两组差异有统计学意义(P<0.05);滴定12 h,两组疼痛缓解率接近,差异无统计学意义(P>0.05)。两组患者主要不良反应为便秘、恶心呕吐、头晕、口干、嗜睡、尿潴留,经过对症处理均可耐受。结论羟考酮控释片作为止痛背景用药在中重度癌痛滴定中与吗啡即释片的疗效及安全性相当,但止痛治疗的稳定性更佳。 Objective To evaluate the efficacy and safety of oxycodone hydrochloride controlled.release tablets in titration of moderate or severe caner pain for background. Methods Eighty.one patients suffering from moderate or severe cancer pain without his.tory of opioid were divided into two groups: Group A(42 cases) used short.acting morphine tablets 10 mg per 4 h to start titration;Group B( 39 cases) used oxycodone hydrochloride controlled.release tablets 10 mg per12 h as background, then patients received titra.tion following NCCN pain’ s guide. After 24 h total opioid dose and translation to oxycodone hydrochloride controlled.release tablets at last were calculated and cumulated. Meanwhile, the efficacy and safety of two groups within 24 hours observation period were compared. Results The total efficiency was 82.9% in group A and 87.2% in group B. Four hours after titrating, pain relieving objective re.sponse rate of group A decreased sharply into 58.3% while group B up to 77.0% with statistically significant differences(P〈0.05). Twelve hours after titrating, the pain relieving objective response rates were similar in two groups, and the difference was no statistically significance(P〉0.05). The main adverse reactions of two groups were including constipation, nausea and vomiting, dizziness, dry mouth, drowsiness and dysuria, which could be relieved by symptomatic treatment. Conclusion Oxycodone hydrochloride controlled.release tablets are effective and safty in relieving moderate or severe cancer pain steady in titration as background.
出处 《临床肿瘤学杂志》 CAS 2015年第8期722-725,共4页 Chinese Clinical Oncology
关键词 肿瘤 羟考酮控释片 癌性疼痛 滴定 Tumor Oxycodone hydrochloride controlled-release tablets Cancer pain Titration
  • 相关文献

参考文献14

  • 1Deandrea S, Montanari M, Moja L, et al. Prevalence of under- treatment in cancer pain. A review of published literature [ J ]. Ann Oncol, 2008, 19(12) :1985-1991.
  • 2Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain : evidence-based recommendations from the EAPC[J]. Lancet Oncol, 2012, 13(2) :e58-68.
  • 3Portenoy RK, Sibirceva U, Smout R, et al. Opioid use and sur- vival at the end of life : a survey of a hospice population [ J 1- J Pain Symptom Manage, 2006, 32(6) :532-540.
  • 4National Comprehensive Cancer Network. NCCN clinical oractice guidelines in oncology: Adult cancer pain, V.L.2014[ EB/OL]. [ 2015-06-15 ]. https://www, ncen. org/store/login/login, aspx?RetumURL = http ://www. necn. org/professionals/physician _gls/ pdf/pain, pdf.
  • 5Lalovic B, Kharasch E, Holler C, et al. Pharmacokinetics and pharmacoclynamics of oral oxyeodone in healthy human subjects: role of circulating active metabolites [ J ]. Clin Pharmacol Ther, 2006, 79(5) :461-479.
  • 6张颖一,韩廷,汪颖,刘璐,王宁,王雅杰.羟考酮控释片用于滴定中度癌痛的疗效观察[J].医学研究杂志,2011,40(4):52-54. 被引量:38
  • 7Schrijvers D. Pain control in cancer: recent findings and trends [ J ]. Ann Oncol, 2007, 18 ( Suppl 9) :ix37-42.
  • 8Salzman RT, Roberts MS, Wild J, et al. Can a controlled-release oral dose form of oxycodone be used as an immediated-release form for the purpose of titrating to stable pain control[ Jl- J Pain Symptom Manage, 1999, 18(4) :271-279.
  • 9Klepstad P, Kaasa S, Jystad A, et al. Immediate-or sustained-re- lease morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial[ J]. Pain, 2003, 101 (1-2) :193-198.
  • 10温一阳,周云,胡晓舒.盐酸羟考酮控释片在癌痛滴定中的应用[J].医药论坛杂志,2012,33(12):111-111. 被引量:6

二级参考文献37

  • 1徐瀚峰,郑勤,张全安,王礼学,丁婕.盐酸羟考酮控释片不同给药方式治疗中重度癌性疼痛的疗效比较[J].实用癌症杂志,2010,25(5):533-534. 被引量:22
  • 2张冠中,谢晓冬,刘大为.盐酸羟考酮控释片治疗晚期癌症疼痛的临床应用[J].中国肿瘤临床,2007,34(2):72-74. 被引量:25
  • 3Kapil R,Nolting A,Roy P,et al.Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen:two randomized,open-label,crossover studies in healthy adult volunteers.Clin Ther,2004,26(12):2015-2025.
  • 4Schrijvers D.Pain control in cancer:recent findings and trends.Ann Oncol,2007,18 Suppl 9:ix37-42.
  • 5Salzman RT,Roberts MS,Wild J,et al.Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control.J Pain Symptom Manage,1999,18(4):271-279.
  • 6Trescot AM,Glaser SE,Hansen H,et al.Effectiveness of opioids in the treatment of chronic non-cancer pain.Pain Physician,2008,11(2 Suppl):S181-200.
  • 7Suzuki T,Morishita M,Ito E,et al.Analgesic efficacy of controlled-release oxycodone in patients with uterine or ovarian cancer.Am J Ther,2008,15(1):31-35.
  • 8Czarnecki ML,Jandrisevits MD,Theiler SC,et al.Controlled-release oxycodone for the management of pediatric postoperative pain.J Pain Symptom Manage,2004,27(4):379-386.
  • 9De Luca A,Coupar IM.Insights into opioid action in the intestinal tract.Pharmacol Ther,1996,69(2):103-115.
  • 10Pappagallo M.Incidence,prevalence,and management of opioid bowel dysfunction.Am J Surg,2001,182(5A Suppl):11S-18S.

共引文献94

同被引文献184

引证文献23

二级引证文献192

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部